Brendan Frey

Digital

pharmaphorum speaks with Brendan Frey, founder and chief innovation officer of Deep Genomics, an AI-first TechBio organisation.

Oncology

As ESMO 2026 continues to get underway, pharmaphorum web editor Nicole Raleigh spoke with Scott Clarke, CEO of CatalYm.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.